Fact Friday: FDA Approves Verzenio (Abemaciclib) for Certain Advanced Breast Cancers

As we near the end of this year’s MSABC campaign, We are pleased to inform you that another step has been made toward our end goal!

On September 17, 2017 it was released that the FDA had approved Verzenio (Abemaciclib) for the treatment of certain advanced breast cancers.

To learn more about Verzenio (Abemaciclib) and what types of advanced cancers it can be used for, please see the official release here.

This is why we continue to Make Strides with your support!

Advertisements